Core Insights - The rise of new consumer brands in Jinan is driven by technological advancements and a focus on meeting consumer needs, showcasing the potential of local industries to innovate and adapt [2][3][4][5][6][7] Group 1: Technological Innovation - Tanghe Tang Biotechnology, a subsidiary of Shengquan Group, has transformed from a traditional industrial player to a high-end food ingredient provider, increasing its revenue from 10 million to over 400 million yuan through the development of a fully automated xylitol production line [3] - Huaxi Biological has shifted from B2B to B2C, investing 3 billion yuan to build the world's largest pilot platform, enabling rapid transformation of research into consumer products and achieving a 44% global market share in hyaluronic acid [4] - The technological breakthroughs in these companies have restructured the supply chain and allowed Jinan's manufacturing sector to penetrate the functional sugar market, with Tanghe Tang aiming for an annual output value of 1 billion yuan in the next 3-5 years [3][4] Group 2: Market Demand and Consumer Focus - Tangpai Group has been addressing the silver economy since 2010, creating a comprehensive supply chain for elderly products, with over 3,000 items integrated into its brand, and establishing the first silver economy center in Shandong [6] - The company has introduced a new consumption model that includes a silver economy center, elderly care display center, and community service stations, ensuring accessibility and affordability of products for the elderly [6] - Weirkan Group has transformed from a traditional meat processing factory to a cold chain service provider, expanding its cold storage capacity from 10,000 tons to 360,000 tons and increasing its distributor network from 200 to over 1,800 [7]

Core Insights - A new wave of consumer brands is emerging in Jinan, focusing on various sectors such as beauty, silver economy products, functional sugars, and cold chain food, driven by technological advancements and market demand [2][5]. Group 1: Company Developments - Huaxi Biological has transitioned from a B2B model supplying hyaluronic acid to a B2C model, investing 3 billion yuan to build the world's largest pilot platform, enhancing its product development capabilities and market responsiveness [4]. - Tanghe Tang Biotechnology, a subsidiary of Shengquan Group, has evolved from a 10 million yuan revenue company in 2008 to over 400 million yuan by leveraging patented technology to produce high-value functional sugars [3]. - Tangpai Group has established a comprehensive supply chain for silver economy products, offering over 3,000 types of products and creating a new consumption model with a focus on elderly care [5]. Group 2: Market Trends - The silver economy is gaining traction in China, with Tangpai Group addressing the supply-demand mismatch by launching 20-30 new products weekly domestically and 100-200 products internationally [5]. - The cold chain logistics sector is being transformed by Weierkang Group, which has expanded its cold storage capacity from 10,000 tons to 360,000 tons, establishing a nationwide distribution network [6][7].

Core Viewpoint - The company reported significant growth in sales revenue and net profit for the first three quarters of 2025, driven by increased demand in AI servers and new energy battery materials [5][10]. Financial Performance - For the first three quarters of 2025, the company achieved sales revenue of 8.072 billion yuan, a year-on-year increase of 12.87% - The net profit attributable to shareholders was 760 million yuan, up 30.81% compared to the same period last year - The net profit after deducting non-recurring gains and losses was 734 million yuan, reflecting a growth of 34.08% year-on-year [5][10]. Product Performance - The company sold 61,100 tons of advanced electronic materials and battery materials, marking a 19.01% increase year-on-year, with sales revenue of 1.237 billion yuan, up 32.23% - The synthetic resin industry maintained resilience, with sales volume reaching 588,700 tons, a 13.90% increase, and sales revenue of 4.096 billion yuan, up 4.64% - Biomass products saw sales of 171,800 tons, a 30.17% increase, with sales revenue of 660 million yuan, up 25.22% [5][11]. Corporate Actions - The company has applied for the issuance of convertible bonds, which is currently under review by the Shanghai Stock Exchange and requires approval from the China Securities Regulatory Commission [7][8].

Core Viewpoint - Shengquan Group (605589.SH) reported a revenue of 8.072 billion yuan for the first three quarters of 2025, reflecting a year-on-year growth of 12.87% [1] - The net profit attributable to shareholders reached 760 million yuan, marking a year-on-year increase of 30.81% [1] - The basic earnings per share stood at 0.9 yuan [1] Financial Performance - Total operating revenue for the first three quarters: 8.072 billion yuan, up 12.87% year-on-year [1] - Net profit attributable to parent company shareholders: 760 million yuan, up 30.81% year-on-year [1] - Basic earnings per share: 0.9 yuan [1]

Core Insights - The company reported a third-quarter revenue of 2.722 billion yuan, representing a year-on-year increase of 7.75% [1] - The net profit for the third quarter was 259 million yuan, showing a year-on-year growth of 3.73% [1] - For the first three quarters of 2025, the company achieved a revenue of 8.072 billion yuan, which is a 12.87% increase compared to the same period last year [1] - The net profit for the first three quarters reached 760 million yuan, reflecting a significant year-on-year growth of 30.81% [1] - The performance improvement is primarily attributed to the increase in product sales [1]

Core Insights - The company reported a revenue of 2,721,538,839.35 yuan for the third quarter of 2025, representing a year-on-year growth of 7.75% [1] - The net profit attributable to shareholders of the listed company was 258,618,062.12 yuan, showing a year-on-year increase of 3.73% [1] Financial Performance - Revenue for Q3 2025: 2,721,538,839.35 yuan, up 7.75% year-on-year [1] - Net profit for Q3 2025: 258,618,062.12 yuan, up 3.73% year-on-year [1]

股票简称：圣泉集团 股票代码：605589 济南圣泉集团股份有限公司 Jinan Shengquan Group Share Holding Co.,Ltd. （山东省济南市章丘区刁镇工业经济开发区） 向不特定对象发行可转换公司债券 募集说明书 （申报稿） 保荐人（主承销商） （注册地址：成都市青羊区东城根上街 95 号） 二零二五年十月 济南圣泉集团股份有限公司 向不特定对象发行可转换公司债券募集说明书 声 明 本公司全体董事、高级管理人员承诺本募集说明书不存在任何虚假、误导性 陈述或重大遗漏，并保证所披露信息的真实、准确、完整。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证 本募集说明书中财务会计报告真实、完整。 中国证监会、上海证券交易所对本次发行所作的任何决定或意见，均不表明 其对申请文件及所披露信息的真实性、准确性、完整性作出保证，也不表明其对 发行人的盈利能力、投资价值或者对投资者的收益作出实质性判断或保证。任何 与之相反的声明均属虚假不实陈述。 根据《证券法》的规定，证券依法发行后，发行人经营与收益的变化，由发 行人自行负责。投资者自主判断发行人的投资价值，自主作出投资决策 ...

公司本次公开发行可转换公司债券（以下简称"本次发行"）事 项尚需履行以下关键程序： 公司本次发行事项尚需通过上交所审核，并获得中国证券监督管 理委员会（以下简称"中国证监会"）作出同意注册的决定后方可实 施。最终能否通过上交所审核并获得中国证监会同意注册的决定及其 时间尚存在不确定性。 公司将严格按照相关法律法规及监管要求，密切关注本次发行事 项的进展情况，并及时履行信息披露义务。敬请广大投资者理性投资， 注意投资风险。 证券代码：605589 证券简称：圣泉集团 公告编号：2025-087 济南圣泉集团股份有限公司 关于向不特定对象发行可转换公司债券申请获得 上海证券交易所受理的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 济南圣泉集团股份有限公司（以下简称"公司"）于 2025 年 10 月 28 日收到上海证券交易所（以下简称"上交所"）出具的《关于受 理济南圣泉集团股份有限公司沪市主板上市公司公开发行证券申请 的通知》（上证上审（再融资）【2025】【320】号），根据《中华人民 共和国证券法》《上市公司证券发 ...

济南圣泉集团股份有限公司 上市保荐书 （成都市青羊区东城根上街 95 号） 2025 年 10 月 国金证券股份有限公司 关于济南圣泉集团股份有限公司 向不特定对象发行可转换公司债券 之 上市保荐书 保荐人（主承销商） 声 明 本保荐机构及保荐代表人根据《中华人民共和国公司法》（以下简称"《公 司法》"）、《中华人民共和国证券法》（以下简称"《证券法》"）、《证券发行 上市保荐业务管理办法》（以下简称"《保荐管理办法》"）《上市公司证券发行 注册管理办法》（以下简称"《注册管理办法》"）、《上海证券交易所上市公司 证券发行上市审核规则》（以下简称"《上市规则》"）、《可转换公司债券管理 办法》等有关法律、行政法规和中国证券监督管理委员会的规定，诚实守信，勤 勉尽责，严格按照依法制订的业务规则、行业执业规范和道德准则出具本上市保 荐书，并保证所出具文件的真实性、准确性和完整性。 3-3-1 | 声 | 明 1 | | --- | --- | | 目 | 录 2 | | 第一节 | 发行人基本情况 4 | | | 一、发行人基本情况 4 | | | 二、发行人的主营业务 4 | | | 三、发行人核心技术 5 | ...

北京市中伦律师事务所 关于济南圣泉集团股份有限公司 向不特定对象发行可转换公司债券的 北京市中伦律师事务所 法律意见书 2025 年 10 月 北京 • 上海 • 深圳 • 广州 • 武汉 • 成都 • 重庆 • 青岛 • 杭州 • 南京 • 海口 • 东京 • 香港 • 伦敦 • 纽约 • 洛杉矶 • 旧金山 • 阿拉木图 Beijing • Shanghai • Shenzhen • Guangzhou • Wuhan • Chengdu • Chongqing • Qingdao • Hangzhou • Nanjing • Haikou • Tokyo • Hong Kong • London • New York • Los Angeles • San Francisco • Almaty | 目 录 | | --- | | 第一部分 | 引言 5 | | --- | --- | | | 一、律师事务所及律师简介 5 | | | 二、律师制作法律意见书及《律师工作报告》的工作过程 6 | | 第二部分 | 正 文 9 | | 一、 | 本次发行的批准和授权 9 | | 二、 | 发行人本次发行的主体 ...